The S-Factor, a New Measure of Disease Severity in Spinocerebellar Ataxia: Findings and Implications

Ashizawa T, Figueroa KP, Perlman SL, Gomez CM, Wilmot GR, Schmahmann JD, Ying SH, Zesiewicz TA, Paulson HL, Shakkottai VG, Bushara KO, Kuo S-H, Geschwind MD, Xia G, Mazzoni P, Krischer JP, Cuthbertson D, Holbert A, Ferguson JH, et al. Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study. Orphanet Journal of Rare Diseases. 2013;8(1):177. https://doi.org/10.1186/1750-1172-8-177.

Article  PubMed  PubMed Central  Google Scholar 

Cancel G, Gourfinkel-An I, Stevanin G, Didierjean O, Abbas N, Hirsch E, Agid Y, Brice A. Somatic mosaicism of the CAG repeat expansion in spinocerebellar ataxia type 3/Machado-Joseph disease. Hum Mutat. 1998;11(1):23–7.  https://doi.org/10.1002/(SICI)1098-1004(1998)11:1<23::AID-HUMU4>3.0.CO;2-M

Casey HL, Gomez CM (1993). Spinocerebellar Ataxia Type 6. In M. P. Adam, H. H. Ardinger, R. A. Pagon, S. E. Wallace, L. J. Bean, G. Mirzaa, & A. Amemiya (Eds.), GeneReviews®. University of Washington, Seattle. http://www.ncbi.nlm.nih.gov/books/NBK1140/

Coarelli G, Darios F, Petit E, Dorgham K, Adanyeguh I, Petit E, Brice A, Mochel F, Durr A. Plasma neurofilament light chain predicts cerebellar atrophy and clinical progression in spinocerebellar ataxia. Neurobiol Dis. 2021;153:105311. https://doi.org/10.1016/j.nbd.2021.105311.

CAS  Article  PubMed  Google Scholar 

Cohen J (1988). Statistical Power Analysis for the Behavioral Sciences (2nd ed.). Routledge. https://doi.org/10.4324/9780203771587

Cornelius N, Wardman JH, Hargreaves IP, Neergheen V, Bie AS, Tümer Z, Nielsen JE, Nielsen TT. Evidence of oxidative stress and mitochondrial dysfunction in spinocerebellar ataxia type 2 (SCA2) patient fibroblasts: effect of coenzyme Q10 supplementation on these parameters. Mitochondrion. 2017;34:103–14. https://doi.org/10.1016/j.mito.2017.03.001.

CAS  Article  PubMed  Google Scholar 

de Mattos EP, Kolbe Musskopf M, Bielefeldt Leotti V, Saraiva-Pereira ML, Jardim LB. Genetic risk factors for modulation of age at onset in Machado-Joseph disease/spinocerebellar ataxia type 3: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2019;90(2):203–10. https://doi.org/10.1136/jnnp-2018-319200.

Article  PubMed  Google Scholar 

Deelchand DK, Joers JM, Ravishankar A, Lyu T, Emir UE, Hutter D, Gomez CM, Bushara KO, Lenglet C, Eberly LE, Öz G. Sensitivity of volumetric magnetic resonance imaging and magnetic resonance spectroscopy to progression of spinocerebellar ataxia type 1. Movement Disorders Clinical Practice. 2019;6(7):549–58. https://doi.org/10.1002/mdc3.12804.

Article  PubMed  PubMed Central  Google Scholar 

Diallo A, Jacobi H, Tezenas du Montcel S, Klockgether T. Natural history of most common spinocerebellar ataxia: a systematic review and meta-analysis. J Neurol. 2021;268(8):2749–56. https://doi.org/10.1007/s00415-020-09815-2.

Article  PubMed  Google Scholar 

Figueroa KP, Coon H, Santos N, Velazquez L, Mederos LA, Pulst SM. Genetic analysis of age at onset variation in spinocerebellar ataxia type 2. Neurology Genetics. 2017;3(3):e155. https://doi.org/10.1212/NXG.0000000000000155.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Gajos KZ, Reinecke K, Donovan M, Stephen CD, Hung AY, Schmahmann JD, Gupta AS. Computer mouse use captures ataxia and parkinsonism, enabling accurate measurement and detection. Mov Disord. 2020;35(2):354–8. https://doi.org/10.1002/mds.27915.

Article  PubMed  Google Scholar 

Grobe-Einsler M, Taheri Amin A, Faber J, Schaprian T, Jacobi H, Schmitz-Hübsch T, Diallo A, Tezenas du Montcel S, Klockgether T. Development of SARA home, a new video-based tool for the assessment of ataxia at home. Mov Disord. 2021;36(5):1242–6. https://doi.org/10.1002/mds.28478.

Article  PubMed  Google Scholar 

Hoche F, Guell X, Vangel MG, Sherman JC, Schmahmann JD. The cerebellar cognitive affective/Schmahmann Syndrome Scale. Brain. 2018;141(1):248–70. https://doi.org/10.1093/brain/awx317.

Article  PubMed  Google Scholar 

Huang S-R, Wu Y-T, Jao C-W, Soong B-W, Lirng J-F, Wu H-M, Wang P-S. CAG repeat length does not associate with the rate of cerebellar degeneration in spinocerebellar ataxia type 3. NeuroImage: Clinical. 2017;13:97–105. https://doi.org/10.1016/j.nicl.2016.11.007.

Article  Google Scholar 

Jacobi H, Bauer P, Giunti P, Labrum R, Sweeney MG, Charles P, Durr A, Marelli C, Globas C, Linnemann C, Schols L, Rakowicz M, Rola R, Zdzienicka E, Schmitz-Hubsch T, Fancellu R, Mariotti C, Tomasello C, Baliko L, et al. The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. Neurology. 2011;77(11):1035–41. https://doi.org/10.1212/WNL.0b013e31822e7ca0.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Jacobi H, du Montcel ST, Bauer P, Giunti P, Cook A, Labrum R, Parkinson MH, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L, Panzeri M, Rakowicz M, Sulek A, Sobanska A, Schmitz-Hübsch T, Schöls L, et al. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study. The Lancet Neurology. 2015;14(11):1101–8. https://doi.org/10.1016/S1474-4422(15)00202-1.

Article  PubMed  Google Scholar 

Kieling C, Rieder CRM, Silva ACF, Saute JAM, Cecchin CR, Monte TL, Jardim LB. A neurological examination score for the assessment of spinocerebellar ataxia 3 (SCA3). Eur J Neurol. 2008;15(4):371–6. https://doi.org/10.1111/j.1468-1331.2008.02078.x.

CAS  Article  PubMed  Google Scholar 

Lamperti C, Naini A, Hirano M, De Vivo DC, Bertini E, Servidei S, Valeriani M, Lynch D, Banwell B, Berg M, Dubrovsky T, Chiriboga C, Angelini C, Pegoraro E, DiMauro S. Cerebellar ataxia and coenzyme Q10 deficiency. Neurology. 2003;60(7):1206–8. https://doi.org/10.1212/01.WNL.0000055089.39373.FC.

CAS  Article  PubMed  Google Scholar 

Langbehn D, Brinkman R, Falush D, Paulsen J, Hayden M, on behalf of an International Huntington’s Disease Collaborative Group. A new model for prediction of the age of onset and penetrance for Huntington’s disease based on CAG length: prediction of the age of onset and penetrance for HD. Clin Genet. 2004;65(4):267–77. https://doi.org/10.1111/j.1399-0004.2004.00241.x.

CAS  Article  PubMed  Google Scholar 

Leotti VB, Vries JJ, Oliveira CM, Mattos EP, Te Meerman GJ, Brunt ER, Kampinga HH, Jardim LB, Verbeek DS. CAG repeat size influences the progression rate of spinocerebellar ataxia type 3. Ann Neurol. 2021;89(1):66–73. https://doi.org/10.1002/ana.25919.

CAS  Article  PubMed  Google Scholar 

Lin C-C, Ashizawa T, Kuo S-H. Collaborative efforts for spinocerebellar ataxia research in the United States: CRC-SCA and READISCA. Front Neurol. 2020;11:902. https://doi.org/10.3389/fneur.2020.00902.

Article  PubMed  PubMed Central  Google Scholar 

Lo RY, Figueroa KP, Pulst SM, Lin C-Y, Perlman S, Wilmot G, Gomez C, Schmahmann J, Paulson H, Shakkottai VG, Ying S, Zesiewicz T, Bushara K, Geschwind M, Xia G, Subramony SH, Ashizawa T, Kuo S-H. Coenzyme Q10 and spinocerebellar ataxias: coenzyme Q10 and spinocerebellar ataxias. Mov Disord. 2015;30(2):214–20. https://doi.org/10.1002/mds.26088.

CAS  Article  PubMed  Google Scholar 

Maas RPPWM, Killaars S, van de Warrenburg BPC, Schutter DJLG. The cerebellar cognitive affective syndrome scale reveals early neuropsychological deficits in SCA3 patients. J Neurol. 2021;268(9):3456–66. https://doi.org/10.1007/s00415-021-10516-7.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Miyai I, Ito M, Hattori N, Mihara M, Hatakenaka M, Yagura H, Sobue G, Nishizawa M. Cerebellar ataxia rehabilitation trial in degenerative cerebellar diseases. Neurorehabil Neural Repair. 2012;26(5):515–22. https://doi.org/10.1177/1545968311425918.

Article  PubMed  Google Scholar 

Monte TL, da Reckziegel ER, Augustin MC, Locks-Coelho LD, Santos ASP, Furtado GV, de Mattos EP, Pedroso JL, Barsottini OP, Vargas FR, Saraiva-Pereira M-L, Camey SA, Leotti VB, Jardim LB, on behalf of Rede Neurogenética. The progression rate of spinocerebellar ataxia type 2 changes with stage of disease. Orphanet Journal of Rare Diseases. 2018;13(1):20. https://doi.org/10.1186/s13023-017-0725-y.

Article  PubMed  PubMed Central  Google Scholar 

Opal, P., & Ashizawa, T. (1993). Spinocerebellar ataxia type 1. In M. P. Adam, H. H. Ardinger, R. A. Pagon, S. E. Wallace, L. J. Bean, G. Mirzaa, & A. Amemiya (Eds.), GeneReviews®. University of Washington, Seattle. http://www.ncbi.nlm.nih.gov/books/NBK1184/

Orr HT, Zoghbi HY. Trinucleotide repeat disorders. Annu Rev Neurosci. 2007;30(1):575–621. https://doi.org/10.1146/annurev.neuro.29.051605.113042.

CAS  Article  PubMed  Google Scholar 

Öz G, Iltis I, Hutter D, Thomas W, Bushara KO, Gomez CM. Distinct neurochemical profiles of spinocerebellar ataxias 1, 2, 6, and cerebellar multiple system atrophy. Cerebellum. 2011;10(2):208–17. https://doi.org/10.1007/s12311-010-0213-6.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Paulson H, Shakkottai V (1993). Spinocerebellar ataxia type 3. In M. P. Adam, H. H. Ardinger, R. A. Pagon, S. E. Wallace, L. J. Bean, G. Mirzaa, & A. Amemiya (Eds.), GeneReviews®. University of Washington, Seattle. http://www.ncbi.nlm.nih.gov/books/NBK1196/

Pulst SM (1993). Spinocerebellar ataxia type 2. In M. P. Adam, H. H. Ardinger, R. A. Pagon, S. E. Wallace, L. J. Bean, G. Mirzaa, & A. Amemiya (Eds.), GeneReviews®. University of Washington, Seattle. http://www.ncbi.nlm.nih.gov/books/NBK1275/

Reetz K, Costa AS, Mirzazade S, Lehmann A, Juzek A, Rakowicz M, Boguslawska R, Schöls L, Linnemann C, Mariotti C, Grisoli M, Dürr A, van de Warrenburg BP, Timmann D, Pandolfo M, Bauer P, Jacobi H, Hauser T-K, Klockgether T, et al. Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6. Brain. 2013;136(3):905–17. https://doi.org/10.1093/brain/aws369.

Article  PubMed  Google Scholar 

Rodríguez-Díaz JC, Velázquez-Pérez L, Rodríguez Labrada R, Aguilera Rodríguez R, Laffita Pérez D, Canales Ochoa N, Medrano Montero J, Estupiñán Rodríguez A, Osorio Borjas M, Góngora Marrero M, Reynaldo Cejas L, González Zaldivar Y, Almaguer Gotay D. Neurorehabilitation therapy in spinocerebellar ataxia type 2: a 24-week, rater-blinded, randomized, controlled trial: neurorehabilitation in SCA2. Mov Disord. 2018;33(9):1481–7. https://doi.org/10.1002/mds.27437.

Article  PubMed  Google Scholar 

Rodríguez-Labrada R, Batista-Izquierdo A, González-Melix Z, Reynado-Cejas L, Vázquez-Mojena Y, Sanz YA, Canales-Ochoa N, González-Zaldívar Y, Dogan I, Reetz K, Velázquez-Pérez L (2021). Cognitive decline is closely associated with ataxia severity in spinocerebellar ataxia type 2: a validation study of the Schmahmann Syndrome Scale. The Cerebellum. https://doi.org/10.1007/s12311-021-01305-z

Schmahmann JD, Gardner R, MacMore J, Vangel MG. Development of a brief ataxia rating scale (BARS) based on a modified form of the ICARS: Brief Ataxia Rating Scale. Mov Disord. 2009;24(12):1820–8. https://doi.org/10.1002/mds.22681.

Article  PubMed  PubMed Central  Google Scholar 

Schmahmann JD, Pierce S, MacMore J, L’Italien GJ (2021). Development and validation of a patient-reported outcome measure of ataxia. Movement Disorders, mds.28670. https://doi.org/10.1002/mds.28670

Schmitz-Hübsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, Giunti P, Globas C, Infante J, Kang J-S, Kremer B, Mariotti C, Melegh B, Pandolfo M, Rakowicz M, Ribai P, Rola R, Schols L, Szymanski S, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66(11):1717–20. https://doi.org/10.1212/01.wnl.0000219042.60538.92.

Article  PubMed  Google Scholar 

Shah VV, Rodriguez-Labrada R, Horak FB, McNames J, Casey H, Hansson Floyd K, El-Gohary M, Schmahmann JD, Rosenthal LS, Perlman S, Velázquez-Pérez L, Gomez CM. Gait variability in spinocerebellar ataxia assessed using wearable inertial sensors. Mov Disord. 2021;36(12):2922–31. https://doi.org/10.1002/mds.28740.

Article  PubMed  Google Scholar 

Subramony SH, May W, Lynch D, Gomez C, Fischbeck K, Hallett M, Taylor P, Wilson R, Ashizawa T, for the Cooperative Ataxia Group. Measuring Friedreich ataxia: interrater reliability of a neurologic rating scale. Neurology. 2005;64(7):1261–2. https://doi.org/10.1212/01.WNL.0000156802.15466.79.

CAS  Article  PubMed  Google Scholar 

Tezenas du Montcel S, Charles P, Ribai P, Goizet C, Le Bayon A, Labauge P, Guyant-Maréchal L, Forlani S, Jauffret C, Vandenberghe N, N’Guyen K, Le Ber I, Devos D, Vincitorio C-M, Manto M-U, Tison F, Hannequin D, Ruberg M, Brice A, Durr A. Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment. Brain. 2008;131(5):1352–61. https://doi.org/10.1093/brain/awn059.

留言 (0)

沒有登入
gif